{"title":"The Sputnik V moment: biotech, biowarfare and COVID-19 vaccine development in Russia and in former Soviet satellite states","authors":"Marek Naczyk, Cornel Ban","doi":"10.1080/21599165.2022.2121117","DOIUrl":null,"url":null,"abstract":"ABSTRACT Why have Russia and Cuba developed and produced vaccines against COVID-19 while Central and Eastern European (CEE) countries that are members of the European Union have only played a marginal role in the global supply of such vaccines? We argue that the answer is to be found in the capacity of Russia’s national security state and entrepreneurs to mobilise historic Soviet advantages as part of a broader security motivated statecraft. CEE countries lacked this legacy and this drive. Similarly, they failed to massively invest – as for example, Cuba has – into potential synergies between public health systems and biotech firms.","PeriodicalId":46570,"journal":{"name":"East European Politics","volume":"10 1","pages":"571 - 593"},"PeriodicalIF":2.0000,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"East European Politics","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.1080/21599165.2022.2121117","RegionNum":2,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"AREA STUDIES","Score":null,"Total":0}
引用次数: 2
Abstract
ABSTRACT Why have Russia and Cuba developed and produced vaccines against COVID-19 while Central and Eastern European (CEE) countries that are members of the European Union have only played a marginal role in the global supply of such vaccines? We argue that the answer is to be found in the capacity of Russia’s national security state and entrepreneurs to mobilise historic Soviet advantages as part of a broader security motivated statecraft. CEE countries lacked this legacy and this drive. Similarly, they failed to massively invest – as for example, Cuba has – into potential synergies between public health systems and biotech firms.